CIBC Private Wealth Group’s Verona Pharma VRNA Stock Holding History

CIBC Private Wealth Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-375	Closed	-$40K	–	3539
2025 Q3	$40K	Sell	375 -461	-55%	-$48.1K	﹤0.01%	1885
2025 Q2	$79.1K	Buy	836 +11	+1%	+$814	﹤0.01%	1490
2025 Q1	$44.7K	Buy	+825	New	+$49.3K	﹤0.01%	1666

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

CIBC Private Wealth Group's VRNA Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 375 shares — an estimated $40K sold.

CIBC Private Wealth Group first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $79.1K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

CIBC Private Wealth Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
CIBC Private Wealth Group sold 375 Verona Pharma shares in Q4 2025, an estimated $40K.
CIBC Private Wealth Group first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
CIBC Private Wealth Group's Verona Pharma position peaked at $79.1K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.